The Irish life sciences sector—spanning biotechnology, pharmaceuticals, and medtech—has consistently remained a dominant force in the global startup ecosystem. As we move deeper into 2026, Ireland continues to produce world-class innovation fueled by highly skilled talent, world-renowned research institutions, and robust financial backing from state agencies like Enterprise Ireland and the Disruptive Technologies Innovation Fund (DTIF).
Following a record-setting €491.3 million raised across venture capital deals in recent years, the Irish ecosystem has transitioned from a hub of early-stage startups to a breeding ground for global scale-ups. In this comprehensive report, we highlight the Top 5 Emerging Pharma and MedTech Companies in Ireland to Watch in 2026. These are indigenous Irish companies currently in a hyper-growth stage, poised to become the next massive players in the industry.
1. LetsGetChecked
Based in Dublin, LetsGetChecked has evolved from a disruptive startup into a global leader in at-home health testing, diagnostics, and telehealth services. As healthcare continues to decentralize, their platform provides patients with clinical-grade testing from the comfort of their homes.
- Website: letsgetchecked.com
- LinkedIn: LetsGetChecked LinkedIn
- Founder & CEO: Peter Foley
- Key Partners: Major US health insurers and Fortune 500 employers.
- Recent Achievements: Expanded their CLIA-certified laboratories and introduced rapid genomic testing panels.
- Funding & Support: Secured a monumental €150 million funding round in late 2025, heavily supported by prominent venture capital and historical backing from Enterprise Ireland.
LetsGetChecked exemplifies the highest overall growth trajectory in the Irish ecosystem. Their ability to secure nine-figure funding rounds and seamlessly penetrate the complex US healthcare market proves their model is not just innovative, but highly scalable.
2. FIRE1
FIRE1 (Foundry Innovation & Research 1) is a Dublin-headquartered connected medical device company. They are revolutionizing the management of heart failure—one of the leading causes of hospitalization globally—through an innovative, implantable sensor that monitors patients remotely.
- Website: fire1med.com
- LinkedIn: FIRE1 LinkedIn
- Founder & CEO: Conor Hanley
- Key Partners: Backed by major global medical device manufacturers and top-tier clinical research hospitals across Europe.
- Recent Achievements: Successfully completed pivotal clinical trials demonstrating significant reductions in heart failure readmissions.
- Funding & Support: Closed a massive €115 million late-stage deal in 2025, marking one of the largest health-tech investment rounds in Europe for the year.
FIRE1 was selected due to their unparalleled clinical trial success. By directly addressing a massive unmet clinical need with a proprietary hardware-software ecosystem, they are redefining standard-of-care for cardiovascular patients.
3. Luminate Medical
Emerging from the world-class MedTech cluster in Galway, Luminate Medical is developing pioneering wearable technologies designed to prevent the devastating side effects of chemotherapy, such as chemotherapy-induced alopecia (hair loss) and peripheral neuropathy.
- Website: luminatemed.com
- LinkedIn: Luminate Medical LinkedIn
- Founders: Aaron Hannon, Dr. Barbara Oliveira, and Martin O'Halloran
- Key Partners: National University of Ireland Galway (NUIG) and leading oncology centers in the US and UK.
- Recent Achievements: Accelerated FDA breakthrough device designation and successful early-stage human trials.
- Funding & Support: Raised $17 million in late 2025, heavily bolstered by grants from the Disruptive Technologies Innovation Fund (DTIF) and Enterprise Ireland's High Potential Start-Up (HPSU) program.
While many pharma companies focus purely on the drug, Luminate focuses on the patient experience. They represent the most innovative patient-centric approach emerging from Ireland, fundamentally improving the quality of life for oncology patients.
4. Deciphex
Deciphex is at the intersection of biotechnology and artificial intelligence. This Dublin-based firm is accelerating drug discovery and pathology by providing digital pathology solutions and AI-driven image analysis, drastically reducing the time it takes for pharmaceutical companies to bring drugs to market.
- Website: deciphex.com
- LinkedIn: Deciphex LinkedIn
- Founder & CEO: Donal O'Shea
- Key Partners: Top 10 global pharmaceutical companies and contract research organizations (CROs).
- Recent Achievements: Launched their next-generation AI pathology platform, processing millions of slides globally.
- Funding & Support: Consistent recipient of Enterprise Ireland innovation vouchers and R&D funding, alongside substantial private Series B/C venture backing.
Deciphex represents the best integration of AI into traditional pharma R&D. By digitizing and automating the pathology workflow, they are solving a major bottleneck in the trillion-dollar pharmaceutical pipeline.
5. ProVerum
Another incredible innovation story out of Dublin, ProVerum is developing a minimally invasive treatment for Benign Prostatic Hyperplasia (BPH), a condition affecting millions of men globally. Their proprietary stent technology offers a safer, outpatient alternative to traditional surgery.
- Website: proverummedical.com
- LinkedIn: ProVerum LinkedIn
- Founder/Leadership: Dr. Paul E. Gilson (Founder) & Richard Fahy (CEO)
- Key Partners: Clinical trial sites across Australia, Europe, and the US.
- Recent Achievements: Unprecedented success in international clinical trials, showing rapid symptom relief with minimal side effects.
- Funding & Support: Successfully raised €73 million in 2025 to fund pivotal global trials and prepare for full commercialization, supported by international medtech syndicates.
ProVerum was selected for their highly efficient path to market. Their regulatory successes with the FDA and EMA indicate that they are not just a research project, but a commercially viable product on the verge of widespread global adoption.
Conclusion
The convergence of state support from Enterprise Ireland, a highly educated workforce, and aggressive private capital has created an unstoppable momentum in the Irish Life Sciences sector. Keep a close eye on LetsGetChecked, FIRE1, Luminate Medical, Deciphex, and ProVerum in 2026—these companies are not just putting Ireland on the map; they are actively redrawing the boundaries of global healthcare.
